世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ラボ自動化市場:自動化の段階別(分析前段階、分析段階、分析後段階、総合ラボ自動化)、機器の種類別(自動リキッドハンドリングシステム、自動マイクロプレートリーダー、自動サンプリングシステム、分析装置、自動保管・検索システム(ASRS)、その他の機器)、用途別(診断学、ゲノムソリューション、微生物学、創薬、プロテオミクスソリューション、その他のアプリケーション)、エンドユーザー(製薬・バイオテクノロジー企業、研究・診断ラボ、その他のエンドユーザー)、主要地域(北米、欧州、アジア太平洋、中東・北アフリカ、中南米):産業動向と世界予測、2023-2035年


Lab Automation Market: Distribution by Stage of Automation (Pre-analytical Stage, Analytical Stage, Post-Analytical Stage and Total Lab Automation), Type of Instrument (Automated Liquid Handling Systems, Automated Microplate Readers, Automated Sampling Systems, Analyzers, Automated Storage and Retrieval Systems (ASRS) and Other Instruments), Application (Diagnostics, Genomic Solutions, Microbiology, Drug Discovery, Proteomic Solutions and Other Applications), End-user (Pharmaceutical and Biotechnology Companies, Research and Diagnostic Laboratories and Other End-Users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2023-2035

ラボオートメーション市場は、2023年には55億ドルに達し、2023年から2035年の予測期間中にCAGR 9.3%で成長すると予測されている。 複雑なバイオ医薬品に対する需要の高まりにより、世界中のラボが分析および... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Roots Analysis
ルーツアナリシス
2023年4月25日 US$4,799
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
231 英語

 

サマリー

ラボオートメーション市場は、2023年には55億ドルに達し、2023年から2035年の予測期間中にCAGR 9.3%で成長すると予測されている。

複雑なバイオ医薬品に対する需要の高まりにより、世界中のラボが分析および製品開発ソリューションを提供するようになってきている。ラボのプロセスの各段階で変数やパラメーターを綿密に管理することは極めて重要である。しかし、従来の手作業では、サンプル汚染の可能性の増加、人件費の増加、時間管理の制約、オペレーターの不一致、即時データアクセスの制限など、いくつかの課題がある。あるNature誌の記事によると、70%以上の科学者が過去に発表された実験の再現が困難であることに直面しており、科学的探求における正確さと信頼性の必要性が強調されている。その結果、エラーを減らし、時間と資源を節約し、再現性を向上させることができる装置の必要性が明らかになった。これに対し、ラボの自動化は、手作業によるプロセスに関連する問題に対処することを目的とした、実行可能なソリューションとして登場した。労働集約的で反復的な作業を自動化することで、自動化技術は研究者が専門的な作業に集中できるようにする。自動化されたサンプリングシステムは、リアルタイムのデータモニタリング、偏差の約65%削減、全体的な生産性の最大80%向上など、さらなる利点を提供する。さらに、ラボの自動化は、データの精度とトレーサビリティを確保しながら、人為的ミスの可能性を減少させるのに役立つ。

この予測では、今後数年間のラボオートメーション市場の大幅な成長を予測しており、その主な原動力は、大幅な進歩と、特定の要件を満たすためのラボオートメーションとそのモジュールの適応性である。

レポート範囲
 本レポートでは、機器のタイプ、アプリケーション、エンドユーザー、主要地域など、さまざまなカテゴリーにわたってラボオートメーション市場を調査しています。
 推進要因、阻害要因、機会、課題などの市場成長要因を分析しています。
 主要市場プレイヤーの競争環境に関する洞察とともに、市場環境における潜在的な利点と障害の評価を提供しています。
 主要5地域に関する市場セグメントの収益予測を予測しています。
 エグゼクティブサマリーは、ラボオートメーション市場の中長期的な現状と予想される進化に関する調査洞察をまとめ、歴史的な進化、段階、利点、課題、将来展望に関するハイレベルな視点を提供します。
 ラボオートメーションの歴史的経過、段階、プロセス、利点、課題、将来展望を詳述した包括的な概要を提示。
 設立年、企業規模、本社所在地、自動化システムの種類、自動化の段階、応用分野、サービスを提供するエンドユーザーなどのパラメータに基づき、約350社のラボ自動化システムメーカーの評価を実施。
 メーカーの競合分析は、会社の設立期間、製品の多様性、様々な自動化段階、応用分野、エンドユーザーにわたる強みなどのパラメータに焦点を当てている。
 北米、欧州、アジア太平洋地域、その他の地域における主要企業の詳細なプロフィールが掲載されており、企業概要、財務詳細(入手可能な場合)、製品ポートフォリオ、最近の開発状況、将来予測が網羅されている。
 ケーススタディでは、設立年、企業規模、本社所在地、ソフトウェアタイプ、展開モード、対象エンドユーザーなどの側面を網羅し、ラボオートメーションソフトウェアプロバイダーの詳細な分析を提供している。
 詳細な分析では、2018年以降にラボオートメーション分野で確立されたパートナーシップを精査し、パートナーシップ年、タイプ、関与するパートナー、オートメーション機器のタイプ、アクティブプレーヤー、パートナーシップ活動の地域分布などのパラメータを評価しています。
 詳細な特許分析では、2018年以降にラボオートメーションに関連して出願/付与された特許を調査し、公開年、特許の種類、管轄、出願人の種類、新たな重点分野、主要プレーヤー、個々の譲受人、特許ベンチマーキング、引用回数に基づく評価などのパラメータを考慮している。

主要市場企業
 アボット
 アントンパール
 BD
 ベックマン・コールター
 ERWEKA
 ロイズ
 オーソ・クリニカル・ダイアグノスティックス
 ポール・コーポレーション
 パーキンエルマー
 ロシュ・ダイアグノスティックス
 シーメンス・ヘルスイニアス
 SYSTAG

ページTOPに戻る


目次

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Overview of Lab Automation
3.2. Historical Evolution of Lab Automation
3.3. Stages of Lab Automation
3.4. Process of Lab Automation
3.5. Advantages of Lab Automation Over Manual Handling
3.6. Challenges associated with Lab Automation
3.7. Future Perspectives
4. MARKET LANDSCAPE
4.1. Lab Automation System Manufacturers: Overall Market Landscape
4.1.1. Analysis by Year of Establishment
4.1.2. Analysis by Company Size
4.1.3. Analysis by Location of Headquarters
4.1.4. Analysis by Company Size and Location of Headquarters
4.1.5. Analysis by Type of Lab Automation System(s)
4.1.6. Analysis by Type of Automated Liquid Handler(s)
4.1.7. Analysis by Type of Automated Microplate(s)
4.1.8. Analysis by Stage(s) of Automation
4.1.9. Analysis by Application Area(s)
4.1.10. Analysis by Type of Lab Automation System(s) and Application Area(s)
4.1.11. Analysis by End-user(s)
4.1.12. Analysis by Stage(s) of Automation and End-user(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Assumptions and Key Parameters
5.2 Methodology
5.3. Competitiveness Analysis: Very Small Companies based in North America (Peer Group I)
5.4. Competitiveness Analysis: Small Companies based in North America (Peer Group II)
5.5 Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
5.5. Competitiveness Analysis: Large Companies based in North America (Peer Group IV)
5.6. Competitiveness Analysis: Very Large Companies based in North America (Peer Group V)
5.7 Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI)
5.8 Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
5.9. Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VII)
5.10. Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
5.11. Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X)
5.12. Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI)
5.13. Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII)
5.14. Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII)
5.15. Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV)
5.16. Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV)
6. COMPANY PROFILES
6.1. Abbott
6.1.1. Company Overview
6.1.2. Financial Information
6.1.3. Lab Automation Product Portfolio
6.1.4. Recent Developments and Future Outlook
6.2. Anton Paar
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Lab Automation Product Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. BD
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Lab Automation Product Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. Beckman Coulter
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Lab Automation Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. ERWEKA
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Lab Automation Product Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. Leuze
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Lab Automation Product Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Ortho Clinical Diagnostics
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Lab Automation Product Portfolio
6.7.4. Recent Developments and Future Outlook
6.8. Pall Corporation
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. Lab Automation Product Portfolio
6.8.4. Recent Developments and Future Outlook
6.9. PerkinElmer
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Lab Automation Product Portfolio
6.9.4. Recent Developments and Future Outlook
6.10. Roche Diagnostics
6.10.1. Company Overview
6.10.2. Financial Information
6.10.3. Lab Automation Product Portfolio
6.10.4. Recent Developments and Future Outlook
6.11. Siemens Healthineers
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Lab Automation Product Portfolio
6.11.4. Recent Developments and Future Outlook
6.12. SYSTAG
6.12.1. Company Overview
6.12.2. Financial Information
6.12.3. Lab Automation Product Portfolio
6.12.4. Recent Developments and Future Outlook
7. CASE STUDY: LAB AUTOMATION SOFTWARE
7.1. Lab Automation Software Providers: Overall Market Landscape
7.1.1. Analysis by Year of Establishment
7.1.2. Analysis by Company Size
7.1.3. Analysis by Location of Headquarters
7.1.4. Analysis by Company Size and Location of Headquarters
7.1.5. Analysis by Type of Software
7.1.6. Analysis by Mode(s) of Deployment
7.1.7. Analysis by Type of Software and Mode(s) of Deployment
7.1.8. Analysis by End-user(s)
7.1.9. Analysis by Type of Software and End-user(s)
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Partnership Models
8.2. Lab Automation: List of Partnerships and Collaborations
8.2.1. Analysis by Year of Partnership
8.2.2. Analysis by Type of Partnership
8.2.3. Analysis by Year and Type of Partnership
8.2.4. Analysis by Type of Partner
8.2.5. Analysis by Year of Partnership and Type of Partner
8.2.6. Analysis by Type of Partnership and Type of Partner
8.2.7. Analysis by Type of Automation Instrument(s)
8.2.8. Analysis by Type of Partnership and Automation Instrument(s)
8.2.9. Most Active Players: Analysis by Number of Partnerships
8.2.10. Analysis by Geography
8.2.10.1. Local and International Agreements
8.2.10.2. Intracontinental and Intercontinental Agreements
9. PATENT ANALYSIS
9.1. Methodology and Key Parameters
9.2. Lab Automation: List of Patents
9.3. Analysis by Patent Publication Year
9.4. Analysis by Publication Year and Type of Patent
9.5. Analysis by Application Year
9.6. Analysis by Patent Jurisdiction
9.7. Analysis by CPC Symbols
9.8. Analysis by Type of Applicant
9.9. Word Cloud: Emerging Focus Areas
9.10. Analysis by Patent Age
9.11. Leading Industry Players: Analysis by Number of Patents
9.12. Leading Non-Industry Players: Analysis by Number of Patents
9.13. Leading Individual Assignees: Analysis by Number of Patents
9.14. Patent Benchmarking: Analysis of Leading Industry Players by Patent Characterization (CPC Symbols)
9.15. Patent Valuation: Methodology and Key Parameters
9.15.1. Analysis by Relative Patent Valuation
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Methodology and Key Assumptions
10.2. Global Lab Automation Market, 2023-2035
10.2.1. Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035
10.2.1.1. Lab Automation Market for Pre-analytical Stage, 2023-2035
10.2.1.2. Lab Automation Market for Analytical Stage, 2023-2035
10.2.1.3. Lab Automation Market for Post-analytical Stage, 2023-2035
10.2.1.4. Lab Automation Market for Total Lab Automation, 2023-2035
10.2.2. Lab Automation Market: Distribution by Type of Instrument, 2023 and 2035
10.2.2.1. Lab Automation Market for Automated Liquid Handling Systems, 2023-2035
10.2.2.2. Lab Automation Market for Automated Microplate Readers, 2023-2035
10.2.2.3. Lab Automation Market for Automated Sampling Systems, 2023-2035
10.2.2.4. Lab Automation Market for Analyzers, 2023-2035
10.2.2.5. Lab Automation Market for Automated Storage and Retrieval Systems (ASRS), 2023-2035
10.2.2.6. Lab Automation Market for Other Instruments, 2023-2035
10.2.3. Lab Automation Market: Distribution by Application, 2023 and 2035
10.2.3.1. Lab Automation Market for Diagnostics, 2023-2035
10.2.3.2. Lab Automation Market for Genomic Solutions, 2023-2035
10.2.3.3. Lab Automation Market for Microbiology, 2023-2035
10.2.3.4. Lab Automation Market for Drug Discovery, 2023-2035
10.2.3.5. Lab Automation Market for Proteomic Solutions, 2023-2035
10.2.3.6. Lab Automation Market for Other Applications, 2023-2035
10.2.4. Lab Automation Market: Distribution by End-user, 2023 and 2035
10.2.4.1. Lab Automation Market for Research and Diagnostic Laboratories, 2023-2035
10.2.4.2. Lab Automation Market for Biotechnology and Pharmaceutical Industries, 2023-2035
10.2.4.3. Lab Automation Market for Other End-users, 2023-2035
10.2.5. Lab Automation Market: Distribution by Key Geographical Regions,2023 and 2035
10.2.5.1. Lab Automation Market in North America, 2023-2035
10.2.5.2. Lab Automation Market in Europe, 2023-2035
10.2.5.3. Lab Automation Market in Asia-Pacific, 2023-2035
10.2.5.4. Lab Automation Market in Middle East and North Africa, 2023-2035
10.2.5.5. Lab Automation Market in Latin America, 2023-2035
11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Africa Medical Supplies Platform
11.2.1. Company Overview
11.2.2. Interview Transcript: Abiodun Sina-Olulana (Production and Supply Management Lead)
11.3. A.S.T. Biomedical
11.3.1. Company Overview
11.3.2. Interview Transcript: Barcella Mauro (Chief Executive Officer)
11.4. Berthold Technologies
11.4.1. Company Overview
11.4.2. Interview Transcript: Anonymous
11.5. Efevre Tech
11.5.1. Company Overview
11.5.2. Interview Transcript: Dimitris Kyriakou (Project Manager and Business Development)
11.6. HSE
11.6.1. Company Overview
11.6.2. Interview Transcript: Patrick Widler (Chief Commercial Officer)
11.7. Inheco
11.7.1. Company Overview
11.7.2. Interview Transcript: Daniel von Sierakowski (Account Manager)
11.8. LabWare
11.8.1. Company Overview
11.8.2. Interview Transcript: Mayookh Sengupta (Sales Manager)
11.9. SciRobotics
11.9.1. Company Overview
11.9.2. Interview Transcript: Shai Kaplan (Co-Founder and Co-Chief Executive Officer)
12. APPENDIX I: TABULATED DATA
13. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

 

ページTOPに戻る


 

Summary

The lab automation market is expected to reach USD 5.5 billion in 2023 anticipated to grow at a CAGR of 9.3% during the forecast period 2023-2035.

Due to the growing demand for complex biopharmaceuticals, laboratories worldwide are increasingly offering analytical and product development solutions. Maintaining meticulous control over variables and parameters at every stage of laboratory processes is crucial. However, traditional manual handling presents several challenges such as increased susceptibility to sample contamination, higher labor costs, time management constraints, operator inconsistencies, and limited instant data access. A Nature article highlighted that over 70% of scientists faced difficulties replicating previously published experiments, emphasizing the need for precision and reliability in scientific pursuits. Consequently, there is a clear need for instruments capable of reducing errors, saving time and resources, and improving reproducibility. In response, lab automation has emerged as a viable solution, aiming to address the issues associated with manual processes. By automating labor-intensive and repetitive tasks, automated technologies allow researchers to focus on specialized operations. Automated sampling systems offer additional benefits including real-time data monitoring, reducing deviations by approximately 65%, and increasing overall productivity by up to 80%. Additionally, lab automation helps decrease the likelihood of human errors while ensuring data precision and traceability.

The forecast predicts substantial growth in the lab automation market in the upcoming years, primarily driven by significant advancements and the adaptability of lab automation and its modules to meet specific requirements.

Report Coverage
 The report examines the lab automation market across various categories, including type of instrument, application, end-user and key geographical regions.
 It analyzes market growth factors such as drivers, restraints, opportunities, and challenges.
 Evaluation of potential advantages and obstacles within the market landscape is provided, along with insights into the competitive environment for leading market players.
 Revenue forecasts for market segments are projected concerning five major regions.
 The executive summary encapsulates research insights on the current state and anticipated evolution of the lab automation market in the medium to long term, offering a high-level perspective on historical evolution, stages, advantages, challenges, and future prospects.
 A comprehensive overview of lab automation detailing its historical progression, stages, processes, benefits, challenges, and future prospects is presented.
 Assessment of approximately 350 lab automation system manufacturers based on parameters like establishment year, company size, headquarters location, types of automation systems, stages of automation, application areas, and served end-users is conducted.
 Competitive analysis of manufacturers focuses on parameters such as company establishment duration, product diversity, and strengths across various automation stages, application areas, and end-users.
 Detailed profiles of key players in North America, Europe, Asia-Pacific, and Rest of the World are provided, encompassing company overviews, financial details (if available), product portfolios, recent developments, and future projections.
 A case study offers an in-depth analysis of lab automation software providers, covering aspects such as establishment year, company size, headquarters location, software types, deployment modes, and served end-users.
 Detailed analysis scrutinizes partnerships established within the lab automation field since 2018, evaluating parameters including partnership year, types, involved partners, automation instrument types, active players, and regional distribution of partnership activities.
 An in-depth patent analysis examines patents filed/granted related to lab automation since 2018, considering parameters like publication year, patent types, jurisdictions, applicant types, emerging focus areas, leading players, individual assignees, patent benchmarking, and valuation based on citation counts.

Key Market Companies
 Abbott
 Anton Paar
 BD
 Beckman Coulter
 ERWEKA
 Leuze
 Ortho Clinical Diagnostics
 Pall Corporation
 PerkinElmer
 Roche Diagnostics
 Siemens Healthineers
 SYSTAG



ページTOPに戻る


Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Overview of Lab Automation
3.2. Historical Evolution of Lab Automation
3.3. Stages of Lab Automation
3.4. Process of Lab Automation
3.5. Advantages of Lab Automation Over Manual Handling
3.6. Challenges associated with Lab Automation
3.7. Future Perspectives
4. MARKET LANDSCAPE
4.1. Lab Automation System Manufacturers: Overall Market Landscape
4.1.1. Analysis by Year of Establishment
4.1.2. Analysis by Company Size
4.1.3. Analysis by Location of Headquarters
4.1.4. Analysis by Company Size and Location of Headquarters
4.1.5. Analysis by Type of Lab Automation System(s)
4.1.6. Analysis by Type of Automated Liquid Handler(s)
4.1.7. Analysis by Type of Automated Microplate(s)
4.1.8. Analysis by Stage(s) of Automation
4.1.9. Analysis by Application Area(s)
4.1.10. Analysis by Type of Lab Automation System(s) and Application Area(s)
4.1.11. Analysis by End-user(s)
4.1.12. Analysis by Stage(s) of Automation and End-user(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Assumptions and Key Parameters
5.2 Methodology
5.3. Competitiveness Analysis: Very Small Companies based in North America (Peer Group I)
5.4. Competitiveness Analysis: Small Companies based in North America (Peer Group II)
5.5 Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
5.5. Competitiveness Analysis: Large Companies based in North America (Peer Group IV)
5.6. Competitiveness Analysis: Very Large Companies based in North America (Peer Group V)
5.7 Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI)
5.8 Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
5.9. Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VII)
5.10. Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
5.11. Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X)
5.12. Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI)
5.13. Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII)
5.14. Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII)
5.15. Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV)
5.16. Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV)
6. COMPANY PROFILES
6.1. Abbott
6.1.1. Company Overview
6.1.2. Financial Information
6.1.3. Lab Automation Product Portfolio
6.1.4. Recent Developments and Future Outlook
6.2. Anton Paar
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Lab Automation Product Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. BD
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Lab Automation Product Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. Beckman Coulter
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Lab Automation Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. ERWEKA
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Lab Automation Product Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. Leuze
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Lab Automation Product Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Ortho Clinical Diagnostics
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Lab Automation Product Portfolio
6.7.4. Recent Developments and Future Outlook
6.8. Pall Corporation
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. Lab Automation Product Portfolio
6.8.4. Recent Developments and Future Outlook
6.9. PerkinElmer
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Lab Automation Product Portfolio
6.9.4. Recent Developments and Future Outlook
6.10. Roche Diagnostics
6.10.1. Company Overview
6.10.2. Financial Information
6.10.3. Lab Automation Product Portfolio
6.10.4. Recent Developments and Future Outlook
6.11. Siemens Healthineers
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Lab Automation Product Portfolio
6.11.4. Recent Developments and Future Outlook
6.12. SYSTAG
6.12.1. Company Overview
6.12.2. Financial Information
6.12.3. Lab Automation Product Portfolio
6.12.4. Recent Developments and Future Outlook
7. CASE STUDY: LAB AUTOMATION SOFTWARE
7.1. Lab Automation Software Providers: Overall Market Landscape
7.1.1. Analysis by Year of Establishment
7.1.2. Analysis by Company Size
7.1.3. Analysis by Location of Headquarters
7.1.4. Analysis by Company Size and Location of Headquarters
7.1.5. Analysis by Type of Software
7.1.6. Analysis by Mode(s) of Deployment
7.1.7. Analysis by Type of Software and Mode(s) of Deployment
7.1.8. Analysis by End-user(s)
7.1.9. Analysis by Type of Software and End-user(s)
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Partnership Models
8.2. Lab Automation: List of Partnerships and Collaborations
8.2.1. Analysis by Year of Partnership
8.2.2. Analysis by Type of Partnership
8.2.3. Analysis by Year and Type of Partnership
8.2.4. Analysis by Type of Partner
8.2.5. Analysis by Year of Partnership and Type of Partner
8.2.6. Analysis by Type of Partnership and Type of Partner
8.2.7. Analysis by Type of Automation Instrument(s)
8.2.8. Analysis by Type of Partnership and Automation Instrument(s)
8.2.9. Most Active Players: Analysis by Number of Partnerships
8.2.10. Analysis by Geography
8.2.10.1. Local and International Agreements
8.2.10.2. Intracontinental and Intercontinental Agreements
9. PATENT ANALYSIS
9.1. Methodology and Key Parameters
9.2. Lab Automation: List of Patents
9.3. Analysis by Patent Publication Year
9.4. Analysis by Publication Year and Type of Patent
9.5. Analysis by Application Year
9.6. Analysis by Patent Jurisdiction
9.7. Analysis by CPC Symbols
9.8. Analysis by Type of Applicant
9.9. Word Cloud: Emerging Focus Areas
9.10. Analysis by Patent Age
9.11. Leading Industry Players: Analysis by Number of Patents
9.12. Leading Non-Industry Players: Analysis by Number of Patents
9.13. Leading Individual Assignees: Analysis by Number of Patents
9.14. Patent Benchmarking: Analysis of Leading Industry Players by Patent Characterization (CPC Symbols)
9.15. Patent Valuation: Methodology and Key Parameters
9.15.1. Analysis by Relative Patent Valuation
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Methodology and Key Assumptions
10.2. Global Lab Automation Market, 2023-2035
10.2.1. Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035
10.2.1.1. Lab Automation Market for Pre-analytical Stage, 2023-2035
10.2.1.2. Lab Automation Market for Analytical Stage, 2023-2035
10.2.1.3. Lab Automation Market for Post-analytical Stage, 2023-2035
10.2.1.4. Lab Automation Market for Total Lab Automation, 2023-2035
10.2.2. Lab Automation Market: Distribution by Type of Instrument, 2023 and 2035
10.2.2.1. Lab Automation Market for Automated Liquid Handling Systems, 2023-2035
10.2.2.2. Lab Automation Market for Automated Microplate Readers, 2023-2035
10.2.2.3. Lab Automation Market for Automated Sampling Systems, 2023-2035
10.2.2.4. Lab Automation Market for Analyzers, 2023-2035
10.2.2.5. Lab Automation Market for Automated Storage and Retrieval Systems (ASRS), 2023-2035
10.2.2.6. Lab Automation Market for Other Instruments, 2023-2035
10.2.3. Lab Automation Market: Distribution by Application, 2023 and 2035
10.2.3.1. Lab Automation Market for Diagnostics, 2023-2035
10.2.3.2. Lab Automation Market for Genomic Solutions, 2023-2035
10.2.3.3. Lab Automation Market for Microbiology, 2023-2035
10.2.3.4. Lab Automation Market for Drug Discovery, 2023-2035
10.2.3.5. Lab Automation Market for Proteomic Solutions, 2023-2035
10.2.3.6. Lab Automation Market for Other Applications, 2023-2035
10.2.4. Lab Automation Market: Distribution by End-user, 2023 and 2035
10.2.4.1. Lab Automation Market for Research and Diagnostic Laboratories, 2023-2035
10.2.4.2. Lab Automation Market for Biotechnology and Pharmaceutical Industries, 2023-2035
10.2.4.3. Lab Automation Market for Other End-users, 2023-2035
10.2.5. Lab Automation Market: Distribution by Key Geographical Regions,2023 and 2035
10.2.5.1. Lab Automation Market in North America, 2023-2035
10.2.5.2. Lab Automation Market in Europe, 2023-2035
10.2.5.3. Lab Automation Market in Asia-Pacific, 2023-2035
10.2.5.4. Lab Automation Market in Middle East and North Africa, 2023-2035
10.2.5.5. Lab Automation Market in Latin America, 2023-2035
11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Africa Medical Supplies Platform
11.2.1. Company Overview
11.2.2. Interview Transcript: Abiodun Sina-Olulana (Production and Supply Management Lead)
11.3. A.S.T. Biomedical
11.3.1. Company Overview
11.3.2. Interview Transcript: Barcella Mauro (Chief Executive Officer)
11.4. Berthold Technologies
11.4.1. Company Overview
11.4.2. Interview Transcript: Anonymous
11.5. Efevre Tech
11.5.1. Company Overview
11.5.2. Interview Transcript: Dimitris Kyriakou (Project Manager and Business Development)
11.6. HSE
11.6.1. Company Overview
11.6.2. Interview Transcript: Patrick Widler (Chief Commercial Officer)
11.7. Inheco
11.7.1. Company Overview
11.7.2. Interview Transcript: Daniel von Sierakowski (Account Manager)
11.8. LabWare
11.8.1. Company Overview
11.8.2. Interview Transcript: Mayookh Sengupta (Sales Manager)
11.9. SciRobotics
11.9.1. Company Overview
11.9.2. Interview Transcript: Shai Kaplan (Co-Founder and Co-Chief Executive Officer)
12. APPENDIX I: TABULATED DATA
13. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Roots Analysis社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Roots Analysis社はどのような調査会社ですか?


Roots Analysisは2013年設立の医薬品・医療機器が専門の調査会社です。 医薬品の製造委託や創薬のデジタル化など、最新の医薬業界の分析を行っています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る